Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript

Mineralys Therapeutics, Inc. (NASDAQ:MLYS) Q1 2026 Earnings Call Transcript May 6, 2026

Mineralys Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.51.

Operator: Welcome to the Mineralys Therapeutics, Inc. First Quarter 2026 conference call. It is now my pleasure to introduce your host, Dan Ferry of Life Science Advisors. Please go ahead, sir.

Dan Ferry: Thank you. I would like to welcome everyone joining us today for our first quarter 2026...